Are the priorities of patients & researchers aligned in the reporting of outcomes in gastric cancer surgery trials?

      Background: Gastric cancer remains a leading cause of cancer-related deaths worldwide and little improvement has been made in long-term survival over the last four decades. Gastrectomy is currently the only treatment modality which can be employed with curative intent, yet surgery is associated with significant short and long-term complications. Surgical trials in this field aim to identify interventions which minimise complications whilst prolonging survival. However, to make research relevant to all key stakeholders, the views of patients should be considered when choosing outcomes to report in these trials.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect